Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Her doctor was on board, so long as Hasan also agreed to start resistance training—something she had only done briefly in the ...

Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced positive data from a 12-week Phase 2a ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Novo Nordisk filed another petition with the FDA seeking to block compounding pharmacies from making versions of one of its GLP-1 drugs ...

Latisha Doty and Alison Bocking have each lost more than 100 lbs. in the last two years—and gained a lifelong friend in the ...

About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income ...

Gemma Collins has shown off a huge body transformation in the new year, revealing she's already two dress sizes smaller this ...

Gemma Collins has wowed fans with her incredible body transformation in recent months, and has now revealed the 'secret' ...

We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at ...